ArticleClinical nuclear medicine2026
The Use of FAPi PET-CT in Recurrent Malignant Uterine PEComa.
Article in Clinical nuclear medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Perivascular epithelioid cell tumor (PEComa) is a rare mesenchymal tumor occurring in ~1 in 1,000,000 patients. It can arise in many parts of the body, and gynecologic PEComa accounts for a quarter of all PEComa cases. We discuss a case of a 43-year-old woman with a history of total abdominal hysterectomy and bilateral salpingo-oophorectomy (TAHBSO) 14 years ago for uterine leiomyoblastoma, which did not require adjuvant treatment. She presented in late 2024 with vague abdominal discomfort and was subsequently found to have a left pelvic malignant PEComa.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.